Dicot has submitted application to start clinical phase 1 trial
Press release: Uppsala, June 1, 2023. Dicot announces today that an application to start clinical trial with the potency drug candidate LIB-01, has been submitted to the Swedish Medical Products Agency.Dicot is developing a new potency drug with the aim to treat erectile dysfunction and premature ejaculation better than existing drugs. The company has previously announced that the clinical phase 1 trial with LIB-01 is planned to start in August. Today, the company has submitted the application to the Swedish Medical Products Agency to start a phase 1 clinical trial. This study is a "